Affiliate Professor, Epidemiology
Head, Center for Observational Research, Amgen Inc.
EducationPhD Epidemiology, University of Washington, 1993
Since 2004, Dr. Critchlow has focused on epidemiologic methods relevant to pharmacoepidemiology, conducting studies and developing observational research strategies in support of drug development and assessment of post-market drug effectiveness and safety. She currently heads the Center for Observational Research at Amgen, Inc.
Dr. Critchlow’s research focuses on pharmacoepidemiology methods to assess the evolving benefit:risk profiles of medications used in clinical practice populations, including application of methods to control for confounding-by-indication in studies of treatment effects, post-marketing drug surveillance studies and longitudinal data analysis using large databases.